Hygeia Healthcare Holdings Co., Ltd. (HK:6078)
:6078
Top Page
Hygeia Healthcare Holdings Co., Ltd.
(6078)
Select Model
Select Model
Rating:62Neutral
Price Target:
HK$14.50
▲(14.26% Upside)
Action:ReiteratedDate:11/22/25
Hygeia Healthcare's overall stock score is driven by strong financial performance, particularly in revenue growth and profitability, despite concerns over cash flow generation. Technical analysis indicates bearish momentum, and valuation is moderate with no dividend yield. The absence of earnings call and corporate events data limits further insights.
Positive Factors
Robust gross profit margin
A 29.36% gross margin signals durable cost control in clinical operations and product sales. Sustained gross margins provide room to invest in facility upgrades and clinical talent, underpinning long-term service quality and competitive positioning in healthcare delivery.
Negative Factors
Null free cash flow in 2024
A null free cash flow result indicates poor cash conversion despite accounting profits, limiting the firm’s ability to self-fund capex, service debt, or return capital. Without improved operating cash generation, strategic flexibility and balance sheet sustainability are at risk over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Robust gross profit margin
A 29.36% gross margin signals durable cost control in clinical operations and product sales. Sustained gross margins provide room to invest in facility upgrades and clinical talent, underpinning long-term service quality and competitive positioning in healthcare delivery.
Read all positive factors
Hygeia Healthcare Holdings Co., Ltd. (6078) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$7.54B
Dividend YieldN/A
Average Volume (3M)7.15M
Price to Earnings (P/E)43.0
Beta (1Y)1.55
Revenue Growth-13.92%
EPS Growth-36.32%
CountryHK
Employees8,169
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)-0.15
Shares Outstanding618,499,000
10 Day Avg. Volume3,556,037
30 Day Avg. Volume7,151,771
Financial Highlights & Ratios
PEG Ratio-1.17
Price to Book (P/B)1.27
Price to Sales (P/S)1.90
P/FCF Ratio91.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$17.94Price Target Upside41.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)0.82
Revenue Forecast (FY)HK$4.37B
Hygeia Healthcare Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
Hygeia Healthcare Holdings Co., Limited operates as an oncology healthcare company in the People's Republic of China. The company owns and operates private for-profit hospitals that offer oncology healthcare services, such as tumor screening and g...
How the Company Makes Money
Hygeia Healthcare generates revenue through multiple key streams, including patient services, which encompass hospital admissions, outpatient treatments, and specialized medical procedures. The company also earns income from the sale of healthcare...
Hygeia Healthcare Holdings Co., Ltd. Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
60
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.06B | 4.45B | 4.08B | 3.20B | 2.32B | 1.40B |
| Gross Profit | 827.26M | 1.31B | 1.29B | 1.02B | 744.66M | 471.96M |
| EBITDA | 588.77M | 999.10M | 1.11B | 868.43M | 623.67M | 385.36M |
| Net Income | 337.22M | 598.26M | 682.93M | 476.78M | 441.46M | 170.09M |
Balance Sheet | ||||||
| Total Assets | 10.94B | 10.93B | 10.73B | 7.24B | 6.69B | 4.70B |
| Cash, Cash Equivalents and Short-Term Investments | 672.38M | 651.59M | 755.89M | 884.71M | 1.10B | 2.58B |
| Total Debt | 2.65B | 2.79B | 2.72B | 1.29B | 1.23B | 2.48M |
| Total Liabilities | 4.04B | 4.25B | 4.48B | 2.30B | 2.21B | 359.93M |
| Stockholders Equity | 6.88B | 6.65B | 6.23B | 4.93B | 4.46B | 4.27B |
Cash Flow | ||||||
| Free Cash Flow | 44.76M | 92.02M | -157.98M | 92.26M | -236.84M | -25.77M |
| Operating Cash Flow | 178.17M | 707.13M | 782.84M | 685.38M | 426.25M | 296.13M |
| Investing Cash Flow | -24.67M | -671.09M | -2.86B | -372.06M | -850.85M | -2.48B |
| Financing Cash Flow | -87.30M | -216.56M | 1.78B | -154.21M | 754.50M | 2.17B |
Hygeia Healthcare Holdings Co., Ltd. Technical Analysis
Neutral
12.69
Price Trends
12.86
Negative
12.83
Negative
13.88
Negative
Market Momentum
-0.32
Negative
52.97
Neutral
72.23
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6078, the sentiment is Neutral. The current price of 12.69 is above the 20-day moving average (MA) of 11.92, below the 50-day MA of 12.86, and below the 200-day MA of 13.88, indicating a neutral trend. The MACD of -0.32 indicates Negative momentum. The RSI at 52.97 is Neutral, neither overbought nor oversold. The STOCH value of 72.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:6078.
Hygeia Healthcare Holdings Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$678.82M | 3.30 | 5.29% | 9.14% | 0.47% | 50.46% | |
68 Neutral | HK$6.52B | 12.63 | 14.79% | 2.61% | 16.41% | 32.97% | |
66 Neutral | HK$1.56B | 5.35 | 18.05% | 4.37% | -3.56% | -17.45% | |
66 Neutral | HK$5.06B | 18.12 | 33.08% | 1.97% | 28.53% | 22.34% | |
62 Neutral | HK$7.54B | 43.03 | 0.62% | ― | -13.92% | -36.32% | |
55 Neutral | HK$6.86B | -6.17 | -10.66% | 2.38% | -8.56% | -403.12% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
HK:6078
Hygeia Healthcare Holdings Co., Ltd.
12.27
-1.25
-9.25%
HK:1526
Rici Healthcare Holdings Ltd.
0.98
-0.11
-10.09%
HK:1951
Jinxin Fertility Group Ltd.
2.50
-0.74
-22.84%
HK:2273
Gushengtang Holdings Limited
27.80
-1.28
-4.40%
HK:2373
Beauty Farm Medical & Health Industry, Inc.
20.18
4.42
28.05%
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
2.03
0.22
12.15%
Hygeia Healthcare Holdings Co., Ltd. Corporate Events
Hygeia Healthcare Announces Share Repurchase Plan
Dec 15, 2025
Hygeia Healthcare Holdings Co., Ltd. announced a proposed on-market share repurchase, intending to buy back up to 61,849,900 shares, equivalent to 10% of its total issued shares. The company believes the current trading price undervalues its intri...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.